NeuroMetrix Return On Equity Over Time
| NURO Stock | USD 4.27 0.03 0.70% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out NeuroMetrix Performance and NeuroMetrix Correlation. NeuroMetrix |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeuroMetrix. If investors know NeuroMetrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeuroMetrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.51) | Revenue Per Share 2.157 | Quarterly Revenue Growth (0.51) | Return On Assets (0.28) | Return On Equity (0.43) |
The market value of NeuroMetrix is measured differently than its book value, which is the value of NeuroMetrix that is recorded on the company's balance sheet. Investors also form their own opinion of NeuroMetrix's value that differs from its market value or its book value, called intrinsic value, which is NeuroMetrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeuroMetrix's market value can be influenced by many factors that don't directly affect NeuroMetrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeuroMetrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if NeuroMetrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeuroMetrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Return On Equity Analysis
Compare NeuroMetrix and related stocks such as Heart Test Laboratories, ReShape Lifesciences, and Inspira Technologies Oxy Return On Equity Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HSCS | (12.1496) | (12.1496) | (12.1496) | (12.1496) | (12.1496) | (12.1496) | (12.1496) | (12.1496) | (12.1496) | (12.1496) | 1.3517 | 0.756 | (2.1 K) | (0.9027) | (0.95) |
| RSLS | 2.8373 | (1.2972) | (1.9756) | (1.7563) | (3.9209) | (6.9423) | (7.9486) | (0.4428) | (2.563) | (3.0784) | (1.493) | (1.3443) | (12.6233) | (1.709) | (1.79) |
| IINN | 1.3655 | 1.3655 | 1.3655 | 1.3655 | 1.3655 | 1.3655 | 1.3655 | 1.3655 | 1.3655 | 0.9877 | 4.2447 | (0.8333) | (0.3121) | (1.9669) | (1.87) |
| BBLG | 0.153 | 0.153 | 0.193 | 1.1963 | 1.1963 | 2.4427 | 2.4356 | 0.8399 | 0.5153 | 0.2886 | 0.1333 | (0.245) | 0.117 | (3.079) | (2.93) |
| NUWE | (7.2659) | (3.5239) | (1.0862) | (0.4206) | (0.8758) | (2.1841) | (8.988) | (0.8241) | (2.8693) | (9.1025) | (0.9705) | (0.7545) | (1.1754) | (6.2937) | (5.98) |
| TIVC | (1.7495) | (1.7495) | (1.7495) | (1.7495) | (1.7495) | (1.7495) | (1.7495) | (1.7495) | (1.7495) | (1.7495) | 3.4639 | (0.64) | (2.7813) | (2.3028) | (2.19) |
| NAOV | 1.2359 | 1.2359 | 0.696 | 0.6033 | 0.4713 | 13.799 | 1.1329 | (1.3663) | (8.9719) | (4.2982) | (1.807) | (2.2623) | (1.6851) | (0.9305) | (0.88) |
| BJDX | 0.2584 | 0.2584 | 0.2584 | 0.2584 | 0.2584 | 0.2584 | 0.2584 | 0.2584 | 0.2584 | 0.2584 | 0.2676 | (0.183) | (0.7996) | (3.4385) | (3.27) |
| VVOS | (1.7697) | (1.7697) | (1.7697) | (1.7697) | (1.7697) | (1.7697) | (1.7697) | (1.7697) | (1.7697) | 3.701 | (0.5215) | (0.7946) | (4.7196) | (33.0487) | (31.4) |
| SINT | 0.2078 | 0.2078 | 0.2363 | 0.0541 | (4.7172) | (1.6802) | (1.1548) | (1.7143) | (1.0301) | (0.9321) | (0.2834) | (0.5541) | (2.8908) | (0.9415) | (0.99) |
NeuroMetrix and related stocks such as Heart Test Laboratories, ReShape Lifesciences, and Inspira Technologies Oxy Return On Equity description
Return on Equity is the amount of NeuroMetrix net income returned as a percentage of NeuroMetrix equity. Return on equity measures NeuroMetrix profitability by revealing how much profit NeuroMetrix generates with the money shareholders have invested. A measure of the profitability of a business in relation to the equity, calculated by dividing net income by shareholder's equity.My Equities
My Current Equities and Potential Positions
| NeuroMetrix | NURO |
Specialization | Health Care, Health Care Equipment & Services |
| Location | Massachusetts; U.S.A |
| Exchange | NASDAQ Exchange |
USD 4.27
Check out NeuroMetrix Performance and NeuroMetrix Correlation. To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
NeuroMetrix technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.